切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2015, Vol. 11 ›› Issue (4) : 511 -515. doi: 10.3877/cma.j.issn.1673-5250.2015.04.016

所属专题: 文献

论著

儿童原发性肾病综合征尿足细胞标志蛋白、足细胞裂孔膜蛋白与尿蛋白关系的研究
苏敏*(), 才绍江, 李真真, 宁芳, 丁美娇   
  1. 150010 哈尔滨市儿童医院
  • 收稿日期:2015-02-03 修回日期:2015-06-12 出版日期:2015-08-01
  • 通信作者: 苏敏

The research relationship between urinary podocalyxin, nephrin and urinary protein in children with primary nephrotic syndrome

Min Su*(), Shaojiang Cai, Zhenzhen Li, Fang Ning, Meijiao Ding   

  1. Harbin Children's Hospital, Harbin 150010, Heilongjiang Province, China
  • Received:2015-02-03 Revised:2015-06-12 Published:2015-08-01
  • Corresponding author: Min Su
引用本文:

苏敏, 才绍江, 李真真, 宁芳, 丁美娇. 儿童原发性肾病综合征尿足细胞标志蛋白、足细胞裂孔膜蛋白与尿蛋白关系的研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2015, 11(4): 511-515.

Min Su, Shaojiang Cai, Zhenzhen Li, Fang Ning, Meijiao Ding. The research relationship between urinary podocalyxin, nephrin and urinary protein in children with primary nephrotic syndrome[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2015, 11(4): 511-515.

目的

探索儿童原发性肾病综合征(NS)蛋白尿与足突损伤间的关系。

方法

选择2013年9月至2014年3月于哈尔滨市儿童医院泌尿内科住院的20例原发性NS患儿为研究对象,并纳入肾病组(n=20)。选择同期于该院门诊体检的10例健康儿童为正常对照组(n=10)。研究组患儿均接受肾上腺糖皮质激素治疗。应用酶联免疫吸附试验(ELISA)方法检测肾病组患儿不同观察时刻及正常对照组儿童随机尿足细胞标志蛋白(PCX)、足细胞裂孔膜蛋白(nephrin)水平,采用免疫比浊法及比色法测定患儿尿蛋白及尿肌酐水平,并计算尿蛋白、尿肌酐比值。

结果

①肾病组患儿尿PCX、nephrin水平和尿蛋白、尿肌酐比值均显著高于正常对照组,且差异有统计学意义(t=2.612,2.843,2.972;P<0.01)。②肾病组患儿激素治疗期间尿PCX、nephrin水平和尿蛋白/尿肌酐比值总体均呈下降趋势。相邻观察时刻的尿PCX与nephrin水平比较,差异均无统计学意义(P>0.05)。治疗第8天尿PCX和nephrin水平较治疗前显著下降,且差异有统计学意义(t=1.934,2.093;P<0.05)。治疗第6天尿蛋白、尿肌酐比值较第4天和治疗前显著下降,且差异也有统计学意义(t=2.042,2.120;P<0.05)。③尿PCX、nephrin水平分别与尿蛋白、尿肌酐比值呈正相关关系(r=0.91,0.92;P<0.01)。

结论

尿PCX、nephrin水平随NS的恢复而逐渐下降,与尿蛋白指标有良好的相关性,对其进行监测可动态观察足细胞变化,对判断肾小球的损伤及恢复情况有一定的临床意义。

Objective

To identify the relationships between proteinuria and foot process damage of primary nephrotic syndrome(NS).

Methods

From September 2013 to March 2014, a total of 20 patients with primary NS were selected as the research group(n=20) in Harbin Children's Hospital.Meanwhile 10 healthy children were selected as normal control group(n=10). The children in research group were treated with adrenal cortex hormone therapy.The levels of podocalyxin (PCX) and nephrin at different observation time in the nephropathy group and at random interval in normal control group were detected by enzyme-linked immunosorbent assay (ELISA) method.The serum levels of urine protein and urine creatinine were measured by the method of turbidimetric inhibition immuno assay and colorimetry.

Results

①The levels of urinary PCX, nephrin and urine protein/creatinine in research group were significantly higher than those of the normal control group(t=2.612, 2.843, 2.972; P<0.01). ②PCX, nephrin and urine protein/urine creatinine levels were decreased during the treatment in research group. There was no significant difference in urine PCX and nephrin between every couple of adjacent observation time (P>0.05). The levels of urinary PCX and nephrin were significantly decreased between the eighth day and before treatment, and the differences were statistically significant(t=1.934, 2.093; P<0.05). The levels of urinary protein/urine creatinine were significantly decreased between the sixth day and the forth day or before treatment, and the differences were also statistically significant(t=2.042, 2.120; P<0.05). ③PCX and nephrin levels were positively correlated with urine protein/urine creatinine levels (r=0.91, 0.92; P<0.01).

Conclusions

The levels of PCX and nephrin decreased with the recovery of NS, and it had a good correlation with urinary protein index, carrying on a quantitative detection of dynamic observation podocyte changes.It has certain clinical significance for judging the glomerular damage and recovery.

表1 两组儿童尿PCX、nephrin水平及尿蛋白、尿肌酐比值比较(±s)
表2 儿童肾病恢复期尿PCX、nephrin水平及尿蛋白、尿肌酐比值比较(±s)
图1 儿童肾病不同观察时刻尿PCX、nephrin水平和尿蛋白/尿肌酐比值比较
图2 尿PCX与尿蛋白/尿肌酐直线相关分析
图3 尿nephrin与尿蛋白/尿肌酐直线相关分析
[1]
中华医学会儿科学分会肾脏病学组.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志2001;39(12):746–749.
[2]
Asao R, Asanuma K, Kodama F,et al. Relationships between levels of urinary podocalyxin,number of urinary podocalyxin,number of urinary podocytes,and histologic injury in adult patients with IgA nephropathy[J].Clin J Am Soc Nephrol20127(9):1385–1393.
[3]
Zhu BLi XFZhu XL,et al. ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephritic syndrome[J].J Nephrol201427(4):411–417.
[4]
Mundel PShankland SJ.Podocyte biology and response to injury[J].J Am Soc Nephrol200213(12):3005–3015.
[5]
邢燕,叶山东.Podocalyxin与糖尿病肾病的关系[J].国际病理科学与临床杂志201131(2):172–174.
[6]
Kanno KKawachi HUchida Y,et al.Urinary sediment podocalyxin in children with glomerular disease[J].Nephron Clin Pract200395(3):91–99.
[7]
Habara PMareckova HMalickova K,et al.Novel flow cytometric method for the detection of podocalyxin-positive elements in urine of pations with glomerulinephritide-first promising results[J].Folia Biol(Praha)201258(2):57–63.
[8]
邢燕,丁洁,范青锋.足细胞分子高表达致阿霉素肾病大鼠发生蛋白尿[J].中华肾脏病杂志200622(1):281–285.
[9]
邓江红,丁洁.从足细胞相关分子的研究认识足突融合现象[J].肾脏病与透析移植20054(14):354–356.
[10]
张焱,黄建萍,肖慧捷,等.甲基泼尼松龙冲击疗法治疗小儿肾病综合征复发疗效观察[J].临床儿科杂志200725(4):274–277.
[11]
刘涛,张碧丽,李莉.检测原发性肾病综合征患儿尿足细胞标志蛋白的临床意义[J].中国当代儿科杂志201214(5):332–335.
[12]
刘海梅,徐虹,高霞.地塞米松影响足细胞活动力的相关分子研究[J].中华肾脏病杂志20129(28):705–709.
[13]
赵向娅,冯晓蓓,王朝晖.尿足细胞及其相关分子在肾小球疾病中的表达[J]. 中国中西医结合肾病杂志20096(6):489–493.
[14]
鲁艳芳,袁军.足细胞相关分子与蛋白尿的关系[J].中国中西医结合儿科学20091(1):74–77.
[15]
张爱华.肾小球足细胞裂孔隔膜分子在蛋白尿发生中的作用[J].医学研究生学报20097(22):673–676.
[1] 唐小清, 何萍, 杨友, 罗霞, 张菊英, 杨鑫, 余进洪. 声触诊弹性成像联合脉冲多普勒超声成像参数与早期慢性肾脏病分期的相关性及临床价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 491-499.
[2] 诸琴红, 夏典平, 葛芳娣, 崔大伟. 抗氧化和炎症指标在糖尿病肾病患者中的临床意义[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 307-311.
[3] 费扬, 赵晗希, 孙丽琴, 楼琴华, 胡骏程. 银杏叶提取物对糖尿病肾病患者的疗效及其对尿液外泌体miR-342-3p的干预研究[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 219-224.
[4] 中华医学会器官移植学分会, 中国医疗保健国际交流促进会肾脏移植学分会. 中国胰肾联合移植临床诊疗指南[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 129-147.
[5] 史彬, 司远. 益气和络方联合缬沙坦治疗气阴两虚兼血瘀证IgA 肾病的疗效观察[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 306-312.
[6] 国文凯, 纪鹏程, 毕靖茹, 谢院生. IgA 肾病的十种治疗措施[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 327-333.
[7] 施麟宵, 洪兰兰, 阳柳, 芶碧珍, 刘畅, 吴欣. 钠-葡萄糖协同转运蛋白2 抑制剂治疗原发性膜性肾病的疗效及其对Th1/Th2 的影响[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 261-267.
[8] 孙顗淼, 张颖. 糖尿病患者急性脑梗死取栓术后发生对比剂肾病的影响因素及预测模型建立[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 188-194.
[9] 张勤灵, 王盼飞, 赵倩文. 尿β2-微球蛋白在原发性膜性肾病预后评估中的作用[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 195-200.
[10] 赵静, 张嘉欣, 高言, 谢席胜. 微小病变肾病的发病机制及治疗研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 207-212.
[11] 孙鼎, 王滨, 陈香美, 陈意志. 热应激肾病的研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(03): 170-176.
[12] 邱岭, 朱旭丽, 浦坚, 邢苗苗, 吴佳玲. 糖尿病肾病患者肠道菌群生态特点与胃肠道功能障碍的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 453-458.
[13] 白璐, 李青霞, 冯一卓, 刘雪倩, 刘若琪, 曲卓敏, 赵凌霞. 丁酸盐治疗糖尿病肾病的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 303-308.
[14] 李忠清, 罗军. 尿蛋白电泳在浆细胞疾病鉴别诊断中的价值[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 217-221.
[15] 张梅, 陈卉, 李转霞, 王瑞, 李林娟. Metrnl和NLRP3炎症小体:糖尿病肾病的潜在诊断标志物[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 193-199.
阅读次数
全文


摘要